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VirF is the master activator of virulence genes of Shigella and its expression is required
for the invasion of the human intestinal mucosa by pathogenic bacteria. VirF was shown
to directly activate the transcription of virB and icsA, which encode two essential proteins
involved in the pathogenicity process, by binding their promoter regions. In this study,
we demonstrate by band shift, enzymatic probing and cross-linking experiments that
VirF, in addition to DNA, can also bind the icsA transcript and RnaG, an antisense
non-coding small RNA that promotes the premature termination of icsA mRNA through
a transcriptional attenuation mechanism. Furthermore, we show that VirF binds in vitro
also other species of RNAs, although with lower specificity. The existence of VirF–RnaG
and VirF-icsA mRNA complexes is confirmed in a pulldown assay carried out under
experimental conditions that very close reproduce the in vivo conditions and that allows
immobilized VirF to “fish” out RnaG and icsA mRNA from a total RNA extract. The VirF
binding sites identified on both icsA mRNA and RnaG contain a 13 nucleotides stretch
(5′-UUUUaGYcUuUau-3′) that is the RNA-converted consensus sequence previously
proposed for the VirF–DNA interaction. Band-shift assays with a synthetic RNA molecule
whose sequence perfectly matches the consensus indicate that this signature plays
a key role also in the VirF–RNA interaction, in particular when exposed in a stem–
loop structure. To further explore the icsA-RnaG-VirF regulatory system, we developed
an in vitro test (RNA–RNA Pairing Assay) in which pairing between icsA mRNA and
synthetic RNAs that reproduce the individual stem–loop motifs of RnaG, was analyzed
in the presence of VirF. This assay shows that this protein can prevent the formation
of the kissing complex, defined as the initial nucleation points for RNA heteroduplex
formation, between RnaG and icsA mRNA. Consistently, VirF alleviates the RnaG-
mediated repression of icsA transcription in vitro. Therefore VirF, by hindering the icsA
transcript-RnaG interaction, exhibits an activity opposed to that usually displayed by
proteins, which generally assist the RNA–RNA interaction; this quite uncommon and
new function and the regulatory implications of VirF as a potential RNA-binding protein
are discussed.
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INTRODUCTION
The gram-negative pathogen Shigella flexneri is the causative
agent of human bacillary dysentery which causes about 1 million
of deaths worldwide each year, the majority of which are children
(Kotloff et al., 2013; Anderson et al., 2016). The VirF protein
(30 kDa) of Shigella, encoded on the primary pathogenicity
island carried by the large virulence plasmid, pINV, is the master
activator leading to the invasivity phenotype (Di Martino et al.,
2016a). Transcription of virF is thermoregulated and occurs
only above the critical temperature of 32–34◦C to prevent the
expression of the virulence genes outside the host (Falconi
et al., 1998). In fact, VirF, once synthesized, triggers a regulatory
cascade, involving the second activator VirB, that, in turn,
induces the expression of the virulence factors required for
invasion and colonization of intestine epithelial cells by this
pathogenic bacterium (Dorman and Porter, 1998; Prosseda et al.,
2002; Parsot, 2005; Schroeder and Hilbi, 2008). Accordingly,
mutants that do not express VirF are avirulent. For this reason,
VirF is currently considered an ideal target for novel antibacterial
agents for treating shigellosis (Koppolu et al., 2013; Emanuele
and Garcia, 2015). While the regulation of virF gene expression
has been extensively investigated (Falconi et al., 1998, 2001;
Prosseda et al., 2004), to date, the protein has remained poorly
characterized at biochemical level and little is known about the
mechanism by which it activates transcription and its possible
interactions with other regulators of virulence in Shigella.
VirF, as other transcriptional regulators of bacterial virulence
(i.e., Rns/CfaD from Escherichia coli, ExsA in Pseudomonas
aeruginosa, ToxT from Vibrio cholerae and LcrF in Yersinia),
is a member of the AraC family (Egan, 2002) and consists
of two domains: a N-terminal dimerization domain and a
C-terminal DNA binding domain. Mutational analysis revealed
that changes of key residues in the two helix-turn-helix (HTH)
motifs predicted to interact with DNA, negatively impact the
ability of VirF to activate the expression of target genes (Porter
and Dorman, 2002). At present, the interaction with DNA and
a direct role of VirF in stimulating promoter activity have been
shown in the regulation of the virulence genes virB and icsA of
Shigella (Tobe et al., 1993; Tran et al., 2011) and in the yop regulon
of Yersinia (Wattiau and Cornelis, 1994). Recently, an opposed
function was observed for a shorter form of VirF (21 kDa) that is
able to bind its own promoter and to negatively autoregulate its
expression (Di Martino et al., 2016b).
IcsA is a structural outer membrane protein which induces
host actin polymerization at one pole of the cell, resulting in
actin-tail formation that propels the bacterium from one cell to
another (Bernardini et al., 1989; Agaisse, 2016). Recently, IcsA
was also shown to promote the adhesion process to host cell,
thus contributing further to the colonization of the intestinal
mucosa (Brotcke Zumsteg et al., 2014). The icsA gene is subjected
to a complex regulation that, in addition to VirF and the
nucleoid protein H-NS, includes also a small non-coding RNA,
named RnaG, encoded on the virulence plasmid pINV of Shigella
flexneri (Giangrossi et al., 2010; Tran et al., 2011). RnaG (450 nt)
is transcribed within the icsA gene and, acting as antisense,
down-regulates icsA expression by a transcriptional attenuation
mechanism. Briefly, RnaG is able to directly interact with icsA
mRNA via a kissing complex establishment and to alter the
structure of the nascent transcript, thus promoting the formation
of a Rho-independent terminator that, in turn, leads to premature
termination of icsA mRNA. Since the RnaG promoter is much
stronger than the icsA promoter, the level of the antisense is
always higher than that of the target mRNA, regardless the
temperature and the VirF transcriptional stimulation (Giangrossi
et al., 2010; Tran et al., 2011). Therefore, another mechanism is
expected to act to relieve the antisense-mediated inhibition of
icsA full transcription.
In this study, we identify a new role for VirF expanding and
deepening our previous knowledge of the multifactor regulation
of icsA. We demonstrate that VirF, in addition to DNA, is
also able to bind RNA, in particular the small non-coding
RnaG and icsA mRNA. In the specific cases of RnaG and icsA
mRNA, the RNA–protein interactions appear so stable that
these RNAs are selectively pulled down by VirF from a crude
cellular RNA extract. By means of different techniques to study
the RNA–protein interaction, we find that VirF exhibits several
binding sites on both RnaG and icsA mRNA. Notably, VirF–RNA
interaction is mediated by the preferential recognition of a 13-bp
consensus sequence and binding sites are mostly located in the
regions involved in formation of the kissing complex between
RnaG and icsA mRNA. According to these results, we report that
VirF bound at these sites can hamper the sense-antisense pairing
and alleviate the RnaG-mediated repression of icsA transcription
in vitro.
MATERIALS AND METHODS
Bacterial Strains, General Procedures,
and DNA Manipulations
The hns fragment of 530 bp (corresponding to the hns mRNA)
was amplified by PCR using the oligonucleotides H238 and
H239 and 10 ng of E. coli MRE600 chromosomal DNA as
template. The DNA product was cloned downstream the T7RNA
polymerase promoter into the EcoRI and BamHI sites of
pSelectTM1 (Promega, Corp.). The resulting pSelecthns was used
to synthesize the hns mRNA. The virB DNA fragment (212 bp)
used to synthesize the leader region of virB mRNA was amplified
by PCR from plasmid pBN1 (Adler et al., 1989) as template. The
amplicon was obtained using the oligonucleotide T7VB (forward
primer) that contains the T7 promoter followed by the sequence
from position+1 to position+24 of virB and the oligonucleotide
VB212 (reverse primer). VirF purification was performed as
described by Tran et al. (2011). Radioactivity associated with
DNA or RNA was detected and quantified by Molecular Imager
(Bio-Rad, mod. FX) and oligonucleotides used in this study are
listed in Supplementary Table S1.
Electrophoretic Mobility Shift Assay
(EMSA)
Electrophoretic mobility shift assay (EMSA) was made using
the following RNAs: RnaG120 (Giangrossi et al., 2010), icsA370,
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mRNA (Giangrossi et al., 2010), hns (this study), virB212 mRNA
(this study), cspD mRNA (Giuliodori et al., 2004) and tRNAMet
(Sigma). Each RNA was transcribed with T7 RNA polymerase
as indicated by Brandi et al. (1996) and labeled with T4
polynucleotide kinase (USB) and [γ-32P]-ATP as described by
Giangrossi et al. (2010). M129 and M130 RNA oligonucleotides
were labeled using T4 polynucleotide kinase and [γ-32P]-ATP.
For M129/130 duplex formation, 5 pmol of M129 32P-labeled
were mixed with 15 pmol of M130 in Annealing buffer (50 mM
KCl, 20 mM Tris HCl-pH 7.5). After incubating at 90–95◦C
for 1 min, the mixture (10 µl) was gradually cooled down to
49◦C and kept at this temperature for 10 min before stopping
on ice. The RNA duplex as formed was used in EMSA. Each
5′-end-labeled RNA (0.05 pmoles of mRNAs or 0.5 pmoles
of oligonucleotides) was incubated for 10 min at 25◦C in gel
retardation buffer (20 mM Tris-HCl, pH 7.5, 50 mM KCl, 10%
glycerol, 0.3 mg/ml Bovine Serum Albumin, 0.02% Nonidet P-40)
with the indicated amounts of VirF and immediately loaded on a
native 7% polyacrylamide gel electrophoresis (PAGE).
Pulldown Assay
Pulldown assay was performed using the Dynabeads His-Tag
Isolation & Pulldown (Novex). 50 µl of Dynabeads were mixed to
80 µg of purified histidine-tagged VirF in Buffer B (10 mM Tris
HCl pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 0.01% N-P40) and
incubated on a roller for 30 min. A control sample containing
only Dynabeads was processed in parallel. Then samples were
washed two times with Buffer B and were incubated for 2 h at
4◦C with 60 µg of total RNA extracted from E. coli HMG11
cells transformed with plasmid pGT1127 (Giangrossi et al., 2010).
Subsequently, supernatants were collected and precipitated with
ethanol whereas the beads were washed three times with
Buffer B containing different NaCl concentrations (100, 200,
and 400 mM). Finally, RNA bound to VirF was eluted from
Dynabeads using Buffer B containing 300 mM imidazole, treated
with phenol–clorophorm (1:1) and then ethanol-precipitated.
RNA Footprinting Assay
Labeled RnaG or icsA370 mRNA (∼1 pmol) denatured for 1 min
at 90◦C, were renatured for 5 min at 32◦C and then incubated
for 3 min without and with different concentrations of VirF
in 15 µl of buffer A (20 mM Hepes-KOH, pH 7.5, 10 mM
MgCl2, 50 mM KCl). RNA was treated with 0.075 U of RNase
T1 (specific for unpaired G), 0.0025 U of RNase T2 (specific
for unpaired C, A, and U) or 0.05 U of RNase V1 (specific
for double-stranded RNA) for 3 min in presence of 1 µg of
tRNA as competitor. The reaction was stopped with an equal
volume of a phenol–chloroform mixture (1:1), and RNA was
precipitated with ethanol. The reaction products were analyzed
on 10% PAGE-urea gel in parallel with 1T1 and OH- ladders
(Donis-Keller et al., 1977).
RNA–protein U.V. Cross-linking Assay
A mixture (8 µl) containing RnaG120 (0.5 pmol) and the [32P]-
labeled G+1H oligonucleotide (2 pmol) was heated at 90◦C for
1 min to denature RNA. Annealing of the primer with RnaG120
was carried out at 32◦C for 5 min in buffer A (see above) in
the presence or absence of VirF. The mixture was transferred
to an ice-cold plate and U.V. irradiated for 1 min using the GS
Gene-linker BioRad (180 mJ, 254 nm bulbs at ∼12 cm from the
U.V. source). Finally the cross-linked RNA was primer-extended
using the AMV Reverse Transcriptase as previously described
(Giangrossi et al., 2010).
RNA–RNA Pairing Assay (RRPA)
The icsA mRNA (2.5 pmol) and the [32P]-labeled RNA
oligonucleotide GR4-48 (0.5 pmol) were denatured separately at
85◦C for 1 min and placed on ice. The GR4-48 oligonucleotide
was renaturated at the indicated temperatures for 5 min in
the presence or absence of VirF before adding the denatured
icsA mRNA. Pairing between icsA mRNA and GR4-48 was
obtained prolonging the incubation for further 10 min at the
same temperature in gel retardation buffer (see above) and then
samples were loaded on 7% PAGE under native conditions.
In Vitro Transcription Assay
The in vitro transcription assay was carried out by incorporating
[α-32P]-UTP into mRNA using the E. coli RNA polymerase
essentially as previously described (Giangrossi et al., 2010). NTPs
concentrations were: ATP, GTP, and CTP 500 µM each, 20 µM of
UTP and 0.2 µCi/µl of [α32P]-UTP. The icsA fragment (304 bp)
to use as DNA template in the in vitro assay, was amplified by
PCR with the oligonucleotides pair G-100/G+187 and plasmid
pGT1129 (Giangrossi et al., 2010). After precipitation, the icsA
transcription products (full-length and truncated transcripts),
were analyzed on 7% PAGE-urea gel.
RESULTS
VirF Binds RNA
VirF was shown, at least in few well-characterized genetic
systems, to bind the promoter regions of its target genes and these
interactions were required to affect their transcription (Tobe
et al., 1993; Wattiau and Cornelis, 1994; Tran et al., 2011; Di
Martino et al., 2016b). As explained before, we were looking
for a regulatory mechanism able to relieve the RnaG-mediated
inhibition of icsA full transcription. For this reason, we tested
whether VirF, in addition to DNA, could also bind RNA. To
verify this hypothesis, we investigated the possible interaction
of VirF with icsA mRNA and RnaG by EMSA. These RNAs
have been chosen because they belong to the icsA–RnaG genetic
system which is regulated by VirF itself. As can be seen in
Figures 1A,B VirF produces retarded bands with both the
icsA370 transcript, consisting of the whole leader region and
part of the coding region, and RnaG120, carrying the entire
antisense sequence (120 nt). About 50% of probe is recovered as
RNA–protein complexes at 21 and 75 nM of VirF with RnaG120
and icsA mRNA, respectively. This result provides the first
evidence that VirF is able to interact with RNA, displaying a∼3.5-
fold higher binding affinity for RnaG than that estimated for the
icsA messenger RNA (Figure 1C). This finding led us to probe
the possible interaction of VirF with a series of RNAs available
in our laboratory, several of which unrelated to the vir system.
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FIGURE 1 | Interaction of VirF with different RNAs. The binding of VirF with icsA370 mRNA (A) and RnaG120 (B) was analyzed by electrophoretic mobility shift
assay (EMSA). The arrowheads indicate the electrophoretic mobilities of unbound RNAs. The interaction of VirF was also investigated using different RNAs
(Supplementary Figure S1). The minimal concentrations of protein required to retard 50% of each RNA tested are reported (C). EMSA experiments were carried out
at least in duplicate.
The selected transcripts were: hns mRNA coding the nucleoid
proteins H-NS, virB mRNA coding a transcriptional activator
of virulence genes of Shigella, cspD mRNA coding a member of
the cold shock protein family of E. coli and the E. coli tRNAMet.
As shown in Supplementary Figure S1, VirF is able to interact
with all the selected RNAs, although the nature of the RNA–
protein complexes and the binding affinities are quite diverse
and strongly dependent on the RNA species. In particular, half of
virB, cspD, and hns transcripts is retarded at VirF concentrations
ranging from 180 to 320 nM while tRNAMet is shifted only at
elevated protein concentrations (500 nM) (Figure 1C). These
experiments demonstrate that, within the limit of accuracy of
EMSA, VirF forms stable complexes with RnaG and icsA mRNA
at a significant lower concentration than that required to bind the
other control RNAs.
In light of this outcome, we tested whether immobilized VirF
was able to “fish” out RnaG and icsA mRNA from a total RNA
extract, to mimic the RNA–protein recognition occurring in vivo.
Pulldown assay shows that both RnaG and icsA mRNA are
recovered when bulk RNA is incubated with the VirF-coated
magnetic beads (Figure 2, lane 3) while are undetected when
empty beads (not complexed with the protein) are used as control
(Figure 2, lane 2). The different levels of the two recovered RNAs
reasonably reflect the higher expression of RnaG with respect
to icsA mRNA, already observed in a previous work (Giangrossi
et al., 2010). This differential expression, confirmed by the primer
extension analysis of the total RNA not subjected to pulldown
(Figure 2, lane 1), results from the transcriptional interference
regulation controlling this genetic system (Giangrossi et al.,
2010). Taken together, these data clearly indicate that, in addition
to an intrinsic capability to stick to RNA, VirF specifically and
selectively recognizes RnaG and icsA transcript, acting, at least
with these RNAs, as a dedicated RNA binding protein.
Identification of VirF Binding Sites on
RnaG120 and icsA370 mRNA
Given that VirF tightly binds RnaG120 (Figures 1, 2), we
performed RNA footprints using RNases T1, T2 and V1 to
FIGURE 2 | VirF pulls down RnaG and icsA mRNA. The pulldown
experiment was carried out as described in Section “Materials and Methods”
adding total RNA to both VirF immobilized on magnetic beads (lane 3) and
beads alone as control sample (lane 2). After several washes, RNA was eluted
from beads by removing the VirF–RNA complexes. Then, samples and 5 µg
of total RNA extract (lane 1) were primer-extended using a mixture of primers
G+110 and G+50 to detect icsA and RnaG, respectively (Giangrossi et al.,
2010). Lanes G and C represent the sequencing reactions.
localize its potential binding sites on this target RNA. As seen
in Figure 3A, VirF interaction causes several alterations of
the sensitivity pattern of RnaG120 to RNases, most of which
are localized on the GH1 domain (nucleotides 15–40). These
changes include few positions protected against RNases T1 and
T2 cleavages on single-stranded regions (loops and internal
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FIGURE 3 | Localization of VirF binding sites on RnaG120 and icsA mRNA. RNA footprints were carried out, as described in Section “Materials and Methods,”
on RnaG120 (A) and on the leader region (370 nt) of icsA mRNA (C). RNases digestions were performed in the absence (–) or in the presence of 250 nM (+) of VirF
in (A) and 250 nM (+) and 500 nM (++) of VirF in (C). M1 and M2 represent OH- and 1T1 ladders, respectively. U.V. cross-linking assays on RnaG120 (B) and icsA
mRNA (D) were carried out without protein (–) and with 250 nM of VirF. Lanes C, U, A, and G correspond to sequencing reactions.
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FIGURE 4 | Secondary structures of relevant RNAs. VirF binding sites, as determined by RNA footprinting and U.V. cross-linking experiments shown in
Figure 3, are reported on the secondary structures of RnaG120 (A) and leader region of icsA370 mRNA (B). GH1, GH2, GH3 motifs of RnaG120 and AH1 and AH2
domains of icsA mRNA have been identified by Giangrossi et al. (2010). Protected nucleotides from T1 and T2 RNases digestion by VirF are circled while positions of
enhanced cleavage by V1 RNase are marked with arrowheads. The VirF–RNA U.V. cross-linked points are indicated with dots. The double-headed arrows indicates
the stem–loop motifs involved in the formation of the kissing complex between RnaG120 and icsA mRNA (Tran et al., 2011). Secondary structures of M129 (C),
M130 (D), and M129/130 RNA duplex (E). The bases represent the sequences perfectly (M129) or partially (on icsA mRNA and RnaG) matching the RNA-converted
consensus sequence determined by Wattiau and Cornelis (1994) for the interaction of VirF with DNA (5′- TTTaGYcTtTat-3′). The sequences reported in red on the
RNA structures share at least 5/13 positions with the consensus. The regions 31–54 of icsA mRNA and 24–42 and 67–85 of RnaG contain two overlapping
consensus-like sequences. Further details are given in Supplementary Figure S3.
bulge) and many positions exhibiting an increased hydrolysis
by RNase V1 on stem structures (Figure 3A). Overall, the
GH2 stem–loop is generally less affected displaying only few
nucleotides hyper-sensitive to RNase V1 cleavage at positions
54–56, 65, and 66. Even less pronounced effects are visible at
GH3 hairpin where the susceptibility to RNases digestion of
RnaG120 alone and that of the VirF–RNA complex does not
significantly vary except for positions 80, 81, and 87 (Figures 3A,
4B). Downstream positions were not analyzed due to technical
limitations. Localization of VirF binding sites on RnaG120 was
confirmed also by means of RNA–protein U.V. cross-linking
studies. In this assay, irradiation of RNA–protein complexes with
ultraviolet light causes the formation of covalent bonds between
VirF and RnaG120. These contact points can be mapped on RNA
as stops (more intense bands) of reverse transcriptase in a primer
extension reaction. The result of this experiment is shown in
Figures 3B, 4B. As expected, VirF remains tightly cross-linked
to GH1 (nucleotides 28–33) whereas very weak interactions are
observed at domains GH2 (nucleotides 66 and 67) and GH3
(nucleotides 79 and 80).
In order to locate possible VirF binding sites on icsA370
mRNA, footprinting and U.V. cross-linking experiments were
carried out also on this transcript that, as RnaG, was efficiently
retarded in gel mobility-shift assays (Figure 1) and pulled
down (Figure 2) by VirF. As seen in Figures 3C,D, 4A, the
two different techniques identify three regions as potential
sites for the VirF–RNA interaction. These discrete sequences
are: (i) the apical loop (nucleotides 30–36) of AH1 arm;
(ii) the stem structure and the basal bulge (nucleotides 60–
65) of AH1 arm; (iii) the basal bulge (nucleotides 77–79
and 99–103) and the apical loop (nucleotides 84–86) of
AH2 arm. Therefore, the results of the U.V. cross-linking
experiments, fully consistent with the enzymatic probing data,
strongly suggest that the domains GH1 of RnaG and AH1
and AH2 of icsA mRNA are the preferential targets of VirF
(Figures 4A,B).
Sequence and Structure Specificity of
VirF–RNA Interaction
By means of DNase I footprinting experiments on the lcrGVH-
yopBD operon, Wattiau and Cornelis (1994) proposed, for the
interaction of VirF with DNA, the 13-bp conserved sequence
TTTaGYcTtTat (nucleotides with a frequency ≥ 60% are in
uppercase and Y indicates pyrimidines). According to this
study and to further investigate the determinants of the VirF–
RNA interaction, we designed two synthetic RNAs, to be
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FIGURE 5 | VirF binds the GH1 domain of RnaG through the preferential recognition of a signature sequence. EMSA was carried out, as a function of the
indicated VirF concentrations, using the following 32P-labeled RNAs: M129 and M130 (A); M129-130 duplex (B); GR4-48 and GR49-80 (C). Signals associated to
bound RNAs were quantified and expressed as percentage of total radioactivity (D).
used in EMSA, that share the same stem–loop structure but
carry (M129) or not (M130) the potential VirF recognition
motif (Figures 4C,D). The gel shown in Figure 5A and the
relative quantification (Figure 5D) clearly reveal that VirF binds
M129, but not M130. However, a higher VirF concentration
is required to shift the short M129 RNA compared to icsA
mRNA and RnaG (Figure 1), indicating that the identified 13-
bp consensus sequence is an element necessary but not fully
sufficient for the interaction of VirF with the RNA. Notably,
the sequences of M129 and M130 are complementary so that
they could be annealed to yield a RNA duplex (Figure 4E).
Comparing the binding capacity of VirF with the M129 and
M129/130 RNAs emerges that this protein, particularly at
lower concentrations (<1 µM), interacts less efficiently with
its target sequence when this is buried within a RNA duplex
(Figures 5B,D and Supplementary Figure S2). Overall, these
data suggest that, in addition to the signature sequence, other
factors (i.e., RNA structure, relative position of certain bases
within the structure itself, number of close binding sequences)
may contribute to the recognition process of specific RNA
regions by VirF (see Discussion). Notably, AH1, AH2, and
GH1 domains that were recognized as preferential binding
sites of VirF, all contain consensus-like sequences (bases in
red in Figures 4A,B) partially exposed in internal or apical
loops.
VirF Preferentially Targets the GH1
Domain of RnaG
We have previously shown that the ability of the non-coding
RnaG (450 nt) to prematurely terminate icsA transcription
resides in its antisense region (nucleotides 1–120) which
hybridizes to the cognate messenger RNA. Complete pairing
passes through the formation of an intermediate, the kissing
complex, in which GH1 contacts AH2 whereas GH2 contacts
AH1 whereas GH3 is dispensable (Figure 4). These interactions
provide the initial nucleation points for RNA hetero-duplex
propagation and are required for the establishment of icsA
attenuation by RnaG (Giangrossi et al., 2010; Tran et al.,
2011).
The evidence of a clear detectable VirF binding site on GH1
domain allowed to suppose that VirF, bound to RnaG, could
interfere with the RNA–RNA interaction by hiding the sequences
critical for the formation of kissing complex between sense
and antisense RNAs. To verify this hypothesis and to study
the interaction of VirF with the individual structural domains
of RnaG, we designed two RNA oligonucleotides reproducing
the GH1 (GR4-48) and GH2 (GR49-80) motifs. Initially, these
synthetic RNAs were used to carry out EMSA experiments.
As seen in Figure 5C, VirF retards both the GR4-48 and
GR49-80 oligonucleotides indicating that its target sites are
independent and binding occurs even when they are separated
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FIGURE 6 | VirF disfavors the interaction of the GH1 domain of RnaG
with icsA mRNA. (A) Pairing Assay was performed at 37 and 42◦C as
described in Section “Materials and Methods” using the indicated amounts of
VirF and the GR4-48 RNA corresponding to the GH1 domain of RnaG. Lane
C1 is a control sample containing the labeled GR4-48 oligo only. Lane C2 is a
control sample containing the labeled GR4-48 RNA in presence of VirF (2 µM)
but in absence of icsA370 mRNA. (B) The radioactivity associated to the
32P-labeled GR4-48 paired with the “cold” icsA370 mRNA has been
quantified and expressed as percentage of the hetero-duplex formed without
VirF (lanes marked with 0).
and individually assayed. Importantly, VirF exhibits, within the
limit of accuracy of this type of analysis, a 2.5-fold higher capacity
to interact with GR4-48 (∼50% bound RNA at 1 µM of protein)
than with GR49-80 (∼45% bound RNA at 2.7 µM of protein)
(Figure 5D). This result, in agreement with RNA footprints
and U.V. cross-linking assays, confirms that GH1 represents the
primary anchorage point recognized by the protein.
VirF Hampers the Formation of the icsA
mRNA–RnaG Duplex and Ultimately
Alleviates the RnaG-Mediated
Repression of icsA Transcription
The outcomes so far presented prompted us to analyze the
effect of the VirF–GH1 interaction on RnaG-icsA mRNA
pairing. To this purpose, we developed an in vitro test
called “RNA–RNA Pairing Assay” (RRPA), in which the heat-
denatured icsA370 messenger was added to a reaction mixture
containing the 5′-end-labeled GR4-48 and VirF. Then, the
free GR4-48 oligonucleotide and that hybridized with the icsA
mRNA were electrophoretically resolved under native conditions
and radioactivity associated with the RNA hetero-duplex was
quantified. RRPA was performed at two temperatures (37 and
42◦C) and VirF concentrations (Figure 6A). Increasing amounts
(from 1 to 2 µM) of VirF cause a progressive reduction of
bound GR4-48 suggesting that this protein blocks the interaction
between the GH1 domain of RnaG and icsA mRNA. This effect is
clearly detectable at 37◦C and becomes very pronounced at 42◦C
(Figure 6B).
Next, by means of an in vitro assay, we investigated
the transcriptional attenuation of icsA by RnaG120 as a
function of increasing concentrations of VirF. According to
Giangrossi et al. (2010), RnaG determines the appearance
of a truncated icsA transcript due to the formation of
an intrinsic terminator on the target mRNA. Under the
experimental conditions used (Figure 7), termination products
promoted by RnaG120 represented about 70% of all transcription
events. VirF addition causes lower levels of transcriptional
termination of icsA (30%), indicating that this protein is able
to alleviate, albeit not completely, the repressive action of
RnaG possibly by sequestering the RnaG itself and its target
mRNA.
DISCUSSION
In the last decade, there has been an explosion in the
discovery of bacterial small regulatory RNAs (sRNAs) and
in the identification of their targets. Most of characterized
sRNAs function by base-pairing with their target mRNAs
and fall into two categories: trans-encoded and cis-encoded
RNAs. trans-encoded sRNAs have multiple target mRNAs and
regulation is exerted via the interactions of short and imperfect
complementary sequences. cis-encoded sRNAs, also known as
antisense RNAs (asRNA), are transcribed from the opposite DNA
strand of established coding sequences and hence share fully
complementary with their targets. In the majority of cases, both
trans- and cis-encoded small RNAs act at post-transcriptional
level by inhibiting the function of target RNAs. Multiple aspects
concerning small regulatory RNAs in bacteria are reviewed in
Georg and Hess (2011), Gottesman and Storz (2011), Storz
et al. (2011), Caldelari et al. (2013), Brantl and Brückner (2014),
Bobrovskyy et al. (2015), Papenfort and Vanderpool (2015),
Wagner and Romby (2015). Despite the large number of sRNAs
recently discovered by deep-sequencing based methods Sharma
and Vogel (2014), clear physiological roles and mechanisms
of action have been established only for a small number
of them. Even less is known about proteins associated with
regulatory sRNAs and how these proteins may modulate their
activities.
Few years ago, we have identified the first regulatory antisense
RNA, encoded by the virulence plasmid pINV of S. flexneri. This
RNA, named RnaG, represses by a transcriptional attenuation
mechanism, the expression of IcsA (Giangrossi et al., 2010), an
invasion protein required for host colonization by pathogenic
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FIGURE 7 | Effects of VirF on the RnaG-mediated repression of icsA.
The in vitro transcription test programmed with icsA was performed, as
described in Section “Materials and Methods,” in presence of 2 pmol of
RnaG120 as a function of increasing amounts of VirF. Full-length and
truncated mRNAs transcribed in the presence and in the absence of VirF were
resolved in 7% PAGE-urea gel. The termination products are expressed as
percentage of the total transcription. Data represent the average of at least
three independent experiments and standard deviation is indicated.
bacteria. Currently, three other small RNAs, that regulate
virulence genes, have been identified and characterized in Shigella
(Fris and Murphy, 2016). In addition to RnaG, we found that
the activity of icsA promoter is modulated by three other
mechanisms (Giangrossi et al., 2010; Tran et al., 2011): (i) direct
stimulation of icsA transcription by VirF at 37◦C; (ii) H-NS-
mediated inhibition of icsA mRNA synthesis; (iii) transcriptional
interference, being icsA and RnaG promoters convergent and 120
nt apart.
A deep investigation on the icsA–RnaG genetic system with
a focus on the role of VirF, has led us to identify a new
property for this protein. In fact, VirF known so far to solely
bind DNA, can also interact with RNA as demonstrated in
this work. Due to the complexity of the overall regulatory
mechanism governing icsA expression and to the objective
difficulties to evaluate the individual and combined contributions
of each factor in vivo, we chose to study this new feature
of VirF by means of an in vitro approach. Gel mobility shift
assays show that VirF binds icsA mRNA and RnaG very tightly
although it is able to associate also with other RNAs (hns,
virB, cspD mRNAs and tRNA) (Figure 1 and Supplementary
Figure S1). Within the limit of accuracy of this technique,
binding capacity varies in a very broad range from ∼20 nM
for RnaG to ∼500 nM for tRNA, suggesting that the nature
(i.e., sequence and structure) of the RNA itself mediates the
interaction of VirF. Searching for the determinants of the
VirF–RNA interaction, we performed an in silico analysis that
revealed the presence of several sequences on both RnaG and
icsA mRNA, shearing a similarity with the degenerated logo
TTTaGYcTtTat, previously identified by Wattiau and Cornelis
(1994). Notably, the positions of these consensus-like sequences
almost completely match the VirF binding sites mapped on
these two RNAs (Figure 4). Furthermore, their primary role
is validated by the fact that VirF binding capacity is strongly
impaired with a RNA oligonucleotide (M130) that lacks this
13-bp conserved motif. Accordingly, VirF shows a higher binding
affinity (∼2.5-fold) for domain GH1 of RnaG, which contains
two overlapping sequences matching in 6/13 and 9/13 positions
the consensus, than for domain GH2, that has only a highly
degenerated motif (5/13 matching positions), as clearly proved
by the EMSA experiment carried out with the separated domains
(Figure 5). Finally, similar sequences, although with lower
frequency and conservation, have been found also the other
RNAs retarded by VirF (Supplementary Figures S1, S3). A deeper
inspection of prominent VirF sites on RnaG120 and icsA mRNA
evidences that they are characterized by a U-rich single-stranded
region (loops or bulges) adjacent to a helix which places part of
the recognized bases into a structural context that reproduces
the natural condition occurring in DNA. This circumstance is
particularly evident at the apical hairpins of GH1 and AH1 and
at the internal bulge of AH2 (Figure 4). In this context, the
unpaired U-stretch seems to play a key role. In fact, VirF binds
better the target sequence arranged in a stem–loop structure with
respect to the same sequence entirely paired in a RNA duplex
(Figure 5). Thus, multiple elements (structurally distinct motif of
RNA, exposition of given bases and adjacent signature sequences)
can concomitantly contribute to the recognition process of RNA
by VirF.
RNA loop–loop interactions are frequently used to trigger the
initial recognition between two RNA molecules. Such pairing,
involving exposed nucleotides, originates the kissing complex
(Wagner and Romby, 2015; Durand et al., 2016). In a previous
study, we have elucidated the secondary structures of the 5′-
end of icsA mRNA (∼150 nt) and RnaG120, identifying those
nucleotides required for establishing the kissing complex between
the sense and antisense RNAs. In particular, a mutational analysis
of RnaG revealed that: (i) the apical loop of GH2 pairs with the
basal bulge of AH1; (ii) the apical loop and the internal bulge of
GH1 anneal with structurally similar motifs present on AH2; (iii)
the GH3 domain is not involved in icsA mRNA–RnaG pairing.
The secondary structures of these cognates RNAs, including their
initial contact points as determined by Tran et al. (2011), are
shown in Figure 4. As mentioned above, our analysis of the
VirF–RNA interaction, overall suggests that this protein has two
primary target sites: the GH1 domain of RnaG and (being RnaG
the natural icsA antisense) its complementary region on icsA
mRNA, the AH2 arm. These regions actively participate to the
formation of kissing complex. The schematic model of Figure 8
shows that, by masking at least one of the pairing sequences
(GH1 and AH2), independently of its location on RnaG or
icsA mRNA, VirF could prevent the formation of a functional
kissing complex thereby allowing the synthesis of the full-length
icsA transcript. Furthermore, several points of hypersensitivity
to V1 RNase cleavage (a double-stranded specific ribonuclease)
induced by VirF interaction are found at GH1 and GH2 stems
of RnaG (Figure 3A). This observation suggests that VirF may
contribute to stabilize the RNA duplex thus trapping RnaG into
its native structure, a rigid state functionally unable to hybridize
Frontiers in Microbiology | www.frontiersin.org 9 April 2017 | Volume 8 | Article 650
fmicb-08-00650 April 12, 2017 Time: 15:9 # 10
Giangrossi et al. VirF Binds RNA
FIGURE 8 | Regulatory mechanism of the icsA-RnaG-VirF system. (A) In the absence of VirF, RnaG forms a hetero-duplex with the nascent icsA message.
This results in the formation of a terminator hairpin, transcription is attenuated and an abortive RNA is released. (B) When VirF is present, it interacts with both icsA
mRNA and RnaG preventing the sense–antisense pairing. Thus the 5′ region of the newly transcribed icsA transcript folds into the AH1 and AH2 stem–loop motifs
that, acting as an antiterminator structure, allows transcription of the icsA full-length mRNA.
with icsA mRNA. Our conclusions are supported by three main
lines of evidence. First of all, RnaG and icsA mRNA are selectively
pulled down by VirF from a total RNA preparation under
competitive conditions that close mimics those existing in vivo
(Figure 2). Secondly, VirF is able to alleviate the termination of
icsA transcription in vitro by targeting RnaG (Figure 7). Finally,
the yield of the hetero-duplex formed between the GH1 domain
of RnaG and icsA mRNA increases as a function of temperature
from 32 to 42◦C, as shown in the RRPA assay of Supplementary
Figure S4. This means that at temperatures ≥ 37◦C there is
more icsA mRNA–RnaG complex, a condition that represses
icsA transcription. However, VirF is able to hamper this sense-
antisense pairing in a temperature-mediated manner, being
its effect more pronounced at temperatures ≥ 37◦C (RRPA
assays shown in Figure 6 and Supplementary Figure S4). The
relieve of the RnaG-mediated attenuation of icsA caused by
VirF binding may ensure that bacterial invasion is maintained
in vivo when the host responds to severe Shigella infection
with high fever. In summary, transcription of icsA can be
activated at host temperature by VirF through two not mutually
exclusive mechanisms: by directly stimulating the activity of
icsA promoter (Tran et al., 2011) and by hindering the
formation of the repressive icsA mRNA–RnaG complex (this
study).
Except for VirF, the icsA–RnaG system is properly regulated
in absence of other RNA helper proteins and is likely
Hfq-independent (Giangrossi et al., 2010). In addition to this
genetic system, two other cases of dedicated RNA binding
proteins, modulating antisense RNAs activity have been reported.
These proteins are Rom (Rop) and FinO involved in the
replication control of ColE1 and F plasmids, respectively.
Whereas Rom stabilizes the kissing product formed by RNA I
and RNA II through conversion of an unstable early intermediate
to a more stable complex (Eguchi and Tomizawa, 1990), FinO
facilitates the loop-to loop-interactions between the asRNA FinP
and traJ mRNA (Arthur et al., 2003). Unlike these proteins
that assist the RNA–RNA interaction, VirF negatively affects
the fate of the kissing complex formed by RnaG and icsA
transcript. This is quite an uncommon function for a protein
able to bind RNA. To our knowledge, the icsA-RnaG-VirF
three components system is the first well-studied case in which
this kind of interplay takes place, providing new mechanistic
aspects for the overall comprehension of riboregulation in
bacteria.
Unlike many other DNA binding proteins, VirF seems
capable of recognizing either the DNA sequences and
their RNA counterparts. Although this property is rather
uncommon, it is worth mentioning that also two important
DNA binding proteins, namely H-NS (Brescia et al., 2004;
Park et al., 2010) and HU (Balandina et al., 2001), were
found to be able to bind both types of nucleic acid. Our
experiments seem to indicate that VirF recognizes the same
consensus binding sequence on both DNA and RNA. To
collect some other information on this issue, we performed
an in silico analysis using program RNAbindRplus (Walia
et al., 2014), that is able to predict RNA-binding residues
Frontiers in Microbiology | www.frontiersin.org 10 April 2017 | Volume 8 | Article 650
fmicb-08-00650 April 12, 2017 Time: 15:9 # 11
Giangrossi et al. VirF Binds RNA
from primary protein sequences by combining Support Vector
Machine and Homology-based methods. The result of this
analysis indicates that R192, H193, H212, S236, P237, Y239,
N245, T251, P252, K253, and K254 are the residues possibly
involved in the binding to RNA. Notably, these residues are
located in the two H-T-H motifs of this AraC family member and
two of these residues, namely H193 and Y239, were found to be
critical for the binding of VirF to DNA (Rhee et al., 1998; Porter
and Dorman, 2002).
Microarray experiments using E. coli and Shigella cells
expressing or not VirF have led to the identification of a
large set of genes common to both bacteria, that are activated
either directly or indirectly by this regulator (Barbagallo
et al., 2011). These observations, in connection with our
data showing the interaction of VirF with different RNA
species (i.e., mRNAs, small RNA, tRNA), strengthen the
emerging idea that this protein might be a powerful and
flexible global regulator acting at both transcriptional and post-
transcriptional levels and participating to diverse regulatory
networks.
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